Catalyst Wire Dossier Catalyst Wire Dossier

BGB-45035

· BeiGene
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BGB-45035, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis [Phase 2]

See pricing